Feasibility, Appropriateness, Meaningfulness and Effectiveness of Bedside Shift Reporting

June 15, 2021 updated by: University Hospital, Ghent

Patient Participation at the Bedside: Feasibility, Appropriateness, Meaningfulness and Effectiveness of Bedside Shift Reporting. A Matched Controlled Trial

Hospitals face the challenge to continually improve their quality of care. In order to achieve this goal, they have to focus on both improving clinical practice and increasing the involvement of patients in the healthcare process. Both factors are equally important to quality of care. The World Health Organization highlights the role that patients and their family could play in the improvement of healthcare. Active patient participation reduces communication errors, increases patient empowerment and is associated with positive health and psychosocial outcomes. A possible strategy to improve patient participation through communication can be bedside shift report (BSR).

Bedside shift report is a process where shift-to-shift report between nurses is, if approved by the patient, executed at the patient's bedside in order to improve the patient's involvement. Bedside shift report has the potential to result in more patient satisfaction, better clinical outcomes, improvement of health education and enhanced team coherence. Preliminary research indicates that BSR decreases safety incidents and adverse events and readmissions, positively influences staff satisfaction, offers beneficial financial effects by reducing nurses' overtime, and allows direct patient care to start earlier.

Despite of these effects, rigorous and large-scale scientific research on this topic is lacking. Currently, the available evidence is scarce and mostly consists of single case or small-scale studies. Longitudinal results on effectiveness and sustainability of BSR are also unknown or inconclusive. There is a need for an increased number of controlled studies to evaluate the impact of BSR on patient, staff and economic outcomes and its longitudinal results.

The aim of this study is four-folded:

  1. The development and fine-tuning of a BSR-intervention and implementation protocol by using diagnostic interviews, co-design, and pilot studies.
  2. A quantitative evaluation of BSR in comparison with care as usual on patient-related, clinical, and nurse-related outcomes.
  3. A qualitative evaluation of the feasibility, appropriateness and meaningfulness of BSR as a method to improve communication and patient participation with a particular interest in the experience of benefits and disadvantages by healthcare professionals and patients.
  4. A process evaluation of BSR to determine the intervention fidelity and to assess the evolution of BSR over the period of the study (e.g. adaptations, consistent practice).

The study design was based on the Medical Research Council-framework for developing and evaluating complex interventions. Power calculation indicates a minimum of 5 experimental wards with 35 patients should be included in the study. The hospital, the specialization of the ward and the nurse-patient ratio will be used for the matched controlled assignment.

Study Overview

Status

Completed

Intervention / Treatment

Study Type

Interventional

Enrollment (Actual)

750

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Brugge, Belgium, 8000
        • AZ Sint-Jan
      • Eeklo, Belgium, 9900
        • AZ Alma
      • Ghent, Belgium, 9000
        • Ghent University Hospital
      • Ghent, Belgium, 9000
        • AZ Sint-Lucas
      • Hasselt, Belgium, 3500
        • AZ Virge Jessa
      • Kortrijk, Belgium, 8500
        • Az Groeninge
      • Lokeren, Belgium, 9160
        • AZ Lokeren
      • Oudenaarde, Belgium, 9700
        • AZ Oudenaarde

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Patients

Inclusion Criteria:

  • Admitted on a participating hospital ward
  • Be conscious
  • Speak Dutch
  • Participated in at least 3 bedside shift reports

Exclusion Criteria

  • Dementia or other severe cognitive/mental disorders

Nurses

Inclusion Criteria:

  • Work on a participating hospital ward
  • Have at least six months of experience on the ward
  • Have participated in 10 bedside shift reports or more

Exclusion Criteria:

  • No hands-on patient contact
  • Internship

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Supportive Care
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Bedside shift report

The experimental group (nurses and patients) will:

  • develop a tailored BSR-intervention by use of co-design, diagnostic interviews, and pilot testing
  • use the tailored BSR-intervention, with participation of the patient, instead of the regular nurse shift report
Bedside shift report is a process where shift-to-shift report between nurses is, if approved by the patient, executed at the patient's bedside in order to improve the patient's involvement (Anderson & Mangino 2006).
Other Names:
  • Bedside shift handover
No Intervention: No bedside shift report
The control group will not use bedside shift report, but will use the regular nurse shift report without participation of the patient

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in Patient Empowerment
Time Frame: 24 months: 4 data collections during the study (baseline, 12 months, 18 months, 24 months)

The change in Patient Empowerment during the study will be investigated by use of repeated measures. The patterns of change between baseline, 12 months, 18 months, and 24 months will be evaluated.

The data will be collected by use of a questionnaire for patients. A validated tool, the Patient Activation Measure (PAM13), will be used.

24 months: 4 data collections during the study (baseline, 12 months, 18 months, 24 months)

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in Quality of Care
Time Frame: 24 months: 4 data collections during the study (baseline, 12 months, 18 months, 24 months)

The change in Quality of Care during the study will be investigated by use of repeated measures. The patterns of change between baseline, 12 months, 18 months, and 24 months will be evaluated.

The data will be collected by use of a questionnaire for patients. A validated tool, the QPP (Quality of care from the Patient's Perspective), will be used.

24 months: 4 data collections during the study (baseline, 12 months, 18 months, 24 months)
Change in Individualized Care (patient)
Time Frame: 24 months: 4 data collections during the study (baseline, 12 months, 18 months, 24 months)

The change in Individualized Care during the study will be investigated by use of repeated measures. For patients, the patterns of change between baseline, 12 months, 18 months, and 24 months will be evaluated.

The data will be collected by use of a questionnaire for patients. A validated tool, the ICS (Individualized Care Scale), will be used.

24 months: 4 data collections during the study (baseline, 12 months, 18 months, 24 months)
Change in Individualized Care (nurse)
Time Frame: 24 months: 2 data collections during the study (baseline, 24 months)

The change in Individualized Care during the study will be investigated by use of repeated measures. For nurses, the patterns of change between baseline and 24 months will be evaluated.

The data will be collected by use of a questionnaire for nurses. A validated tool, the ICS (Individualized Care Scale), will be used.

24 months: 2 data collections during the study (baseline, 24 months)
Change in Job Satisfaction
Time Frame: 24 months: 2 data collections during the study (baseline, 24 months)

The change in Job Satisfaction during the study will be investigated by use of repeated measures. The patterns of change between baseline and 24 months will be evaluated.

The data will be collected by use of a questionnaire for nurses. A validated tool, the MOAQ-JSS (Michigan Organizational Assessment Questionnaire - Job Satisfaction Subscale), will be used.

24 months: 2 data collections during the study (baseline, 24 months)
Change in Turnover Intention (1)
Time Frame: 24 months: 2 data collections during the study (baseline, 24 months)

The change in Turnover Intention during the study will be investigated by use of repeated measures. The patterns of change between baseline and 24 months will be evaluated.

The data will be collected by use of a questionnaire for nurses. A validated tool, the MOAQ-TIS (Michigan Organizational Assessment Questionnaire - Turnover Intention Subscale), will be used.

24 months: 2 data collections during the study (baseline, 24 months)
Change in Turnover Intention (2)
Time Frame: 24 months: 2 data collections during the study (baseline, 24 months)

The change in Turnover Intention during the study will be investigated by use of repeated measures. The patterns of change between baseline and 24 months will be evaluated.

The data will be collected by use of a questionnaire for nurses. Two questions from the RN4CAST (Nurse Forecasting: Human Resources Planning in Nursing) are used.

24 months: 2 data collections during the study (baseline, 24 months)
Change in Coordination of the Care Process
Time Frame: 24 months: 2 data collections during the study (baseline, 24 months)

The change in Coordination of the Care Process during the study will be investigated by use of repeated measures. The patterns of change between baseline and 24 months will be evaluated.

The data will be collected by use of a questionnaire for nurses. A validated tool, the CPSET-COR (Care Process Self Evaluation Tool - Coordination subscale), will be used.

24 months: 2 data collections during the study (baseline, 24 months)
Change in Communication
Time Frame: 24 months: 2 data collections during the study (baseline, 24 months)

The change in Communication during the study will be investigated by use of repeated measures. The patterns of change between baseline and 24 months will be evaluated.

The data will be collected by use of a questionnaire for nurses. A validated tool, the CPSET-COM (Care Process Self Evaluation Tool - Communication subscale), will be used.

24 months: 2 data collections during the study (baseline, 24 months)
Change in Work Interruptions (1)
Time Frame: 24 months: 2 data collections during the study (baseline, 24 months)

The change in Work Interruptions during the study will be investigated by use of repeated measures. The patterns of change between baseline and 24 months will be evaluated.

The data will be collected by use of a questionnaire for nurses. A non-validated tool to measure nurses' perceptions on work interruptions, developed by the researchers, will be used.

24 months: 2 data collections during the study (baseline, 24 months)
Change in Work Interruptions (2)
Time Frame: 24 months: 2 data collections during the study (baseline, 24 months)

The change in Work Interruptions during the study will be investigated by use of repeated measures. The patterns of change between baseline and 24 months will be evaluated..

The data will be collected from electronic databases from within the participating hospitals that measure the number of work interruptions ('calls for assistance').

24 months: 2 data collections during the study (baseline, 24 months)
Change in Patient Participation
Time Frame: 24 months: 2 data collections during the study (baseline, 24 months)

The change in Patient Participation during the study will be investigated by use of repeated measures. The patterns of change between baseline and 24 months will be evaluated.

The data will be collected by use of a questionnaire for nurses. Five questions from a validated tool, the PaCT-HCW (Patient Participation Culture Tool for Healthcare Workers), will be used.

24 months: 2 data collections during the study (baseline, 24 months)
Change in Hospital Acquired Pressure Ulcers (HAPU)
Time Frame: 24 months: 4 data collections during the study (baseline, 12 months, 18 months, 24 months)

The change in incidence of HAPU's during the study will be investigated by use of repeated measures. The patterns of change between baseline, 12 months, 18 months, and 24 months will be evaluated.

The data will be collected from the patient's medical file. The timeframe for registration is from the admission on the ward until discharge from the ward. Any HAPU's during the patient's stay on the ward on heel and sacrum will registered by use of the NPUAP/EPUAP classification system.

24 months: 4 data collections during the study (baseline, 12 months, 18 months, 24 months)
Change in Patient Falls
Time Frame: 24 months: 4 data collections during the study (baseline, 12 months, 18 months, 24 months)

The change in incidence of Patient Falls during the study will be investigated by use of repeated measures. The patterns of change between baseline, 12 months, 18 months, and 24 months will be evaluated.

The data will be collected from the patient's medical file. The timeframe for registration is admission on the ward until discharge from the ward. Any patient falls during the patient's stay on the ward will registered.

24 months: 4 data collections during the study (baseline, 12 months, 18 months, 24 months)
Change in Unnecessary New Intravenous Drips
Time Frame: 24 months: 4 data collections during the study (baseline, 12 months, 18 months, 24 months)

The change in incidence of Unnecessary New Intravenous Drips during the study will be investigated by use of repeated measures. The patterns of change between baseline, 12 months, 18 months, and 24 months will be evaluated.

The data will be collected from the patient's medical file. The timeframe for registration is from admission on the ward until discharge from the ward with a maximum of 30 days. Newly placed intravenous drips without explicit physician indication will be registered.

24 months: 4 data collections during the study (baseline, 12 months, 18 months, 24 months)
Change in Length of Stay
Time Frame: 24 months: 4 data collections during the study (baseline, 12 months, 18 months, 24 months)

The change in Length of Stay during the study will be investigated by use of repeated measures. The patterns of change between baseline, 12 months, 18 months, and 24 months will be evaluated.

The data will be collected from the patient's medical file. The total length of stay on the ward will be registered.

24 months: 4 data collections during the study (baseline, 12 months, 18 months, 24 months)
Change in Unplanned Readmission
Time Frame: 24 months: 4 data collections during the study (baseline, 12 months, 18 months, 24 months)

The change in incidence of Unplanned Readmissions during the study will be investigated by use of repeated measures. The patterns of change between baseline, 12 months, 18 months, and 24 months will be evaluated.

The data will be collected from the patient's medical file. Readmissions within 30 days in the same hospital will be registered.

24 months: 4 data collections during the study (baseline, 12 months, 18 months, 24 months)
Change in Pain
Time Frame: 24 months: 4 data collections during the study (baseline, 12 months, 18 months, 24 months)

The change in Pain scores during the study will be investigated by use of repeated measures. The patterns of change between baseline, 12 months, 18 months, 24 months will be evaluated.

The data will be collected from the patient's medical file. The timeframe for registration is from admission on the ward until discharge from the ward. The first pain score after the nurse shift report will be registered each day.

24 months: 4 data collections during the study (baseline, 12 months, 18 months, 24 months)
Change in Duration of the shift report
Time Frame: 24 months: 4 data collections during the study (baseline, 12 months, 18 months, 24 months)

The change in the Duration of the Shift Report during the study will be investigated by use of repeated measures. The patterns of change between baseline, 12 months,18 months, and 24 months will be evaluated.

Thirteen shift reports will be recorded during each data collection point. Based on the recordings, the duration of the shift report will be calculated.

24 months: 4 data collections during the study (baseline, 12 months, 18 months, 24 months)
Feasibility
Time Frame: 12 months: 1 data collection (12 months)
The data concerning the experienced Feasibility of BSR will be collected by use of individual, semi-structured interviews (patients) and semi-structured focus group interviews (nurses) using an interview guide. The data will be collected at 12 months.
12 months: 1 data collection (12 months)
Applicability
Time Frame: 12 months: 1 data collection (12 months)
The data concerning the experienced Applicability of BSR will be collected by use of individual, semi-structured interviews (patients) and semi-structured focus group interviews (nurses) using an interview guide. The data will be collected at 12 months.
12 months: 1 data collection (12 months)
Meaningfulness
Time Frame: 12 months: 1 data collection (12 months)
The data concerning the experienced Meaningfulness of BSR will be collected by use of individual, semi-structured interviews (patients) and semi-structured focus group interviews (nurses) using an interview guide. The data will be collected at 12 months.
12 months: 1 data collection (12 months)
Change in Intervention Fidelity
Time Frame: 24 months: 2 data collections during the study(between 12 months and 18 months; between 18 months and 24 months)

The change in Intervention Fidelity during the study will be investigated by use of repeated measures. The patterns of change will be evaluated.

The data will be collected by use of non-participating observations. A checklist will be used. During each period (12 months until 18 months / 18 months until 24 months) 20 non-participating observations on each ward will be performed.

24 months: 2 data collections during the study(between 12 months and 18 months; between 18 months and 24 months)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Collaborators

Investigators

  • Principal Investigator: Ann Van Hecke, MSc, PhD, Ghent University/Ghent University Hospital
  • Principal Investigator: Kristof Eeckloo, LMM, PhD, Ghent University/Ghent University Hospital
  • Principal Investigator: Wim Van Biesen, MD, PhD, Ghent University/Ghent University Hospital

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

March 1, 2016

Primary Completion (Actual)

April 1, 2018

Study Completion (Actual)

May 1, 2018

Study Registration Dates

First Submitted

February 29, 2016

First Submitted That Met QC Criteria

March 15, 2016

First Posted (Estimate)

March 21, 2016

Study Record Updates

Last Update Posted (Actual)

June 16, 2021

Last Update Submitted That Met QC Criteria

June 15, 2021

Last Verified

June 1, 2021

More Information

Terms related to this study

Other Study ID Numbers

  • HA/RP/2015/086/EC
  • B670201627044 (Other Identifier: Ethics Committee UZ Gent)

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Patient Participation

Clinical Trials on Bedside shift report

Subscribe